Heme binding to human CLOCK affects interactions with the E-box.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
01 10 2019
Historique:
pubmed: 19 9 2019
medline: 9 4 2020
entrez: 19 9 2019
Statut: ppublish

Résumé

The circadian clock is an endogenous time-keeping system that is ubiquitous in animals and plants as well as some bacteria. In mammals, the clock regulates the sleep-wake cycle via 2 basic helix-loop-helix PER-ARNT-SIM (bHLH-PAS) domain proteins-CLOCK and BMAL1. There is emerging evidence to suggest that heme affects circadian control, through binding of heme to various circadian proteins, but the mechanisms of regulation are largely unknown. In this work we examine the interaction of heme with human CLOCK (hCLOCK). We present a crystal structure for the PAS-A domain of hCLOCK, and we examine heme binding to the PAS-A and PAS-B domains. UV-visible and electron paramagnetic resonance spectroscopies are consistent with a bis-histidine ligated heme species in solution in the oxidized (ferric) PAS-A protein, and by mutagenesis we identify His144 as a ligand to the heme. There is evidence for flexibility in the heme pocket, which may give rise to an additional Cys axial ligand at 20K (His/Cys coordination). Using DNA binding assays, we demonstrate that heme disrupts binding of CLOCK to its E-box DNA target. Evidence is presented for a conformationally mobile protein framework, which is linked to changes in heme ligation and which has the capacity to affect binding to the E-box. Within the hCLOCK structural framework, this would provide a mechanism for heme-dependent transcriptional regulation.

Identifiants

pubmed: 31527239
pii: 1905216116
doi: 10.1073/pnas.1905216116
pmc: PMC6778266
doi:

Substances chimiques

ARNTL Transcription Factors 0
BMAL1 protein, human 0
Basic Helix-Loop-Helix Transcription Factors 0
CRY1 protein, human 0
Cryptochromes 0
Ligands 0
NPAS2 protein, human 0
Nerve Tissue Proteins 0
PER1 protein, human 0
Period Circadian Proteins 0
Recombinant Proteins 0
Heme 42VZT0U6YR
DNA 9007-49-2
CLOCK Proteins EC 2.3.1.48
CLOCK protein, human EC 2.3.1.48
Oxygen S88TT14065

Banques de données

PDB
['6QPJ']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

19911-19916

Subventions

Organisme : Biotechnology and Biological Sciences Research Council
ID : BB/L006626/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Biochemistry. 2016 Jul 26;55(29):4047-54
pubmed: 27379473
Biochemistry. 2010 May 25;49(20):4327-38
pubmed: 20411915
J Inorg Biochem. 2012 Mar;108:171-7
pubmed: 22137591
J Neurosci. 2002 Nov 1;22(21):9305-19
pubmed: 12417656
Microbiol Mol Biol Rev. 1999 Jun;63(2):479-506
pubmed: 10357859
Science. 1993 Jan 15;259(5093):381-4
pubmed: 7678352
Chem Rev. 2015 Jul 8;115(13):6491-533
pubmed: 26021768
FEBS Lett. 2007 Jul 31;581(19):3626-33
pubmed: 17451689
FEBS Lett. 2014 Mar 3;588(5):701-4
pubmed: 24440354
Nature. 2012 May 16;485(7399):459-64
pubmed: 22622569
FEBS J. 2006 Jun;273(11):2528-39
pubmed: 16704425
Science. 2012 Jul 13;337(6091):189-94
pubmed: 22653727
Nat Commun. 2016 Nov 10;7:13411
pubmed: 27830695
Biochemistry. 2004 Nov 9;43(44):14189-98
pubmed: 15518569
Science. 2007 Dec 14;318(5857):1786-9
pubmed: 18006707
Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15177-82
pubmed: 9860942
Biochemistry. 2008 Jun 10;47(23):6157-68
pubmed: 18479150
Acc Chem Res. 2006 Jan;39(1):37-43
pubmed: 16411738
Chronobiol Int. 2005;22(3):455-71
pubmed: 16076647
Cell. 1997 May 16;89(4):641-53
pubmed: 9160755
Metallomics. 2012 Aug;4(9):928-36
pubmed: 22885802
Science. 2002 Dec 20;298(5602):2385-7
pubmed: 12446832
Nat Struct Mol Biol. 2007 Dec;14(12):1207-13
pubmed: 18037887
Sci Rep. 2018 Aug 10;8(1):11996
pubmed: 30097595
Proc Natl Acad Sci U S A. 2018 Mar 27;115(13):3249-3254
pubmed: 29531094
J Biol Chem. 2016 Jan 29;291(5):2196-222
pubmed: 26670607
Neuroscience. 2009 Dec 1;164(2):832-41
pubmed: 19698763
Biochemistry. 2005 Mar 29;44(12):4627-35
pubmed: 15779889
Nature. 2004 Jul 22;430(6998):467-71
pubmed: 15269772
Ann N Y Acad Sci. 2012 Aug;1264:103-9
pubmed: 22834651
J Biol Chem. 2003 May 16;278(20):18434-9
pubmed: 12639952
J Biol Chem. 2004 May 7;279(19):20186-93
pubmed: 14982921
Inorg Chem. 2010 Jul 19;49(14):6349-65
pubmed: 20666392
Biochem Biophys Res Commun. 2008 Apr 4;368(2):292-7
pubmed: 18230344
J Inorg Biochem. 2012 Mar;108:188-95
pubmed: 22245004
Nat Rev Mol Cell Biol. 2007 Feb;8(2):139-48
pubmed: 17245414
FEBS J. 2005 Aug;272(16):4153-62
pubmed: 16098197
Chem Rev. 2015 Apr 8;115(7):2532-58
pubmed: 25763468
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303
pubmed: 29788355
Cell. 2001 Jun 1;105(5):683-94
pubmed: 11389837
Cell. 2002 May 3;109(3):307-20
pubmed: 12015981
J Biol Chem. 2017 Jul 7;292(27):11280-11299
pubmed: 28500133
J Inorg Biochem. 2005 Jan;99(1):1-22
pubmed: 15598487
J Biol Chem. 2006 Aug 25;281(34):24512-20
pubmed: 16762924
J Biol Chem. 1994 Feb 11;269(6):4207-14
pubmed: 8307983
Biochemistry. 2007 Jul 10;46(27):8017-23
pubmed: 17580972
Biochemistry. 2004 Mar 16;43(10):2738-46
pubmed: 15005609
Science. 1994 Apr 29;264(5159):719-25
pubmed: 8171325
Structure. 2009 Oct 14;17(10):1282-94
pubmed: 19836329
Mol Neurobiol. 2017 Sep;54(7):4953-4962
pubmed: 27520276
J Biol Chem. 2005 Jun 3;280(22):21358-68
pubmed: 15797872
Cell Res. 2013 Feb;23(2):213-24
pubmed: 23229515
Nat Struct Mol Biol. 2017 Jan;24(1):15-22
pubmed: 27892932

Auteurs

Samuel L Freeman (SL)

School of Chemistry, University of Bristol, BS8 1TS Bristol, United Kingdom.

Hanna Kwon (H)

School of Chemistry, University of Bristol, BS8 1TS Bristol, United Kingdom.

Nicola Portolano (N)

Department of Chemistry, University of Leicester, LE1 7RH Leicester, United Kingdom.
Leicester Institute of Structural and Chemical Biology, University of Leicester, LE1 7RH Leicester, United Kingdom.

Gary Parkin (G)

Department of Chemistry, University of Leicester, LE1 7RH Leicester, United Kingdom.
Leicester Institute of Structural and Chemical Biology, University of Leicester, LE1 7RH Leicester, United Kingdom.

Umakhanth Venkatraman Girija (U)

Department of Chemistry, University of Leicester, LE1 7RH Leicester, United Kingdom.
Leicester Institute of Structural and Chemical Biology, University of Leicester, LE1 7RH Leicester, United Kingdom.

Jaswir Basran (J)

Department of Chemistry, University of Leicester, LE1 7RH Leicester, United Kingdom.
Leicester Institute of Structural and Chemical Biology, University of Leicester, LE1 7RH Leicester, United Kingdom.

Alistair J Fielding (AJ)

School of Pharmacy and Biomolecular Science, Liverpool John Moores University, Liverpool L3 3AF, United Kingdom.

Louise Fairall (L)

Leicester Institute of Structural and Chemical Biology, University of Leicester, LE1 7RH Leicester, United Kingdom.
Department of Molecular and Cell Biology, University of Leicester, LE1 7RH Leicester, United Kingdom.

Dimitri A Svistunenko (DA)

School of Biological Sciences, University of Essex, Colchester, Essex CO4 3SQ, United Kingdom.

Peter C E Moody (PCE)

Leicester Institute of Structural and Chemical Biology, University of Leicester, LE1 7RH Leicester, United Kingdom.
Department of Molecular and Cell Biology, University of Leicester, LE1 7RH Leicester, United Kingdom.

John W R Schwabe (JWR)

Leicester Institute of Structural and Chemical Biology, University of Leicester, LE1 7RH Leicester, United Kingdom.
Department of Molecular and Cell Biology, University of Leicester, LE1 7RH Leicester, United Kingdom.

Charalambos P Kyriacou (CP)

Department of Genetics and Genome Biology, University of Leicester, LE1 7RH Leicester, United Kingdom.

Emma L Raven (EL)

School of Chemistry, University of Bristol, BS8 1TS Bristol, United Kingdom; emma.raven@bristol.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH